Oxetacaine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12532 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 23 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | pseudo-von Willebrand disease | KG + DL |
| 3 | Glanzmann thrombasthenia | KG + DL |
| 4 | uterine polyp | KG + DL |
| 5 | polyp of vocal cord | KG + DL |
| 6 | polyp of middle ear | KG + DL |
| 7 | polyp of ureter | KG + DL |
| 8 | polyp of frontal sinus | KG + DL |
| 9 | polyp of external auditory canal | KG + DL |
| 10 | epulis | KG + DL |
| 11 | polyp of vulva | KG + DL |
| 12 | fibroepithelial polyp | KG + DL |
| 13 | neoplastic polyp | KG + DL |
| 14 | mycotic corneal ulcer | KG + DL |
| 15 | leprosy | KG + DL |
| 16 | candidiasis | KG + DL |
| 17 | tinea corporis | KG + DL |
| 18 | vulvovaginal candidiasis | KG + DL |
| 19 | hyperargininemia | KG + DL |
| 20 | nasal cavity polyp | KG + DL |
| 21 | amenorrhea (disease) | KG + DL |
| 22 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 23 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.